Interleukin-1 beta expression and treatment outcome in acute myelogenous leukemia

Energy-Dependent Shifts of Medium-Scale Anisotropies in Very-High-Energy Cosmic Rays Observed by LHAASO-KM2A.

Physical review letters·2026

Transient Large-Scale Anisotropy in TeV Cosmic Rays due to an Interplanetary Coronal Mass Ejection.

Physical review letters·2026

First Detection of Ultrahigh Energy Emission from Gamma-Ray Binary LS I +61° 303.

Physical review letters·2026

Evidence of Cosmic-Ray Acceleration up to Sub-PeV Energies in the Supernova Remnant IC 443.

Physical review letters·2026

Precise Measurement of the Cosmic Ray Helium Spectrum above 0.1 PeV.

Physical review letters·2026

A REVIEW OF CURRENT CONCEPTS IN THE MANAGEMENT OF BONE DEFECTS IN TRAUMA AND ORTHOPAEDICS.

Georgian medical news·2025

Vasculopathy in the Forecast: Biophysically Altered Red Cells Act as Hemodynamic Hail to Trigger Endothelial Dysfunction.

Blood·2026

Nipocalimab for warm autoimmune hemolytic anemia: results from the phase 2/3 randomized, double-blind ENERGY study.

Blood·2026

Inhibition of nucleoporin 214 depletes leukemia stem cells by promoting heme catabolism and lipid peroxidation.

Blood·2026

International Consensus Criteria for the Diagnosis, Treatment Initiation, and Response Assessment for T-LGL Leukemia.

Blood·2026

Epigenetic markers expand genetic risk estimation in acute myeloid leukemia.

Blood·2026

Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas.

Blood·2026

[Sarcoidosis from an immunological perspective - experience-based diagnosis and treatment with targeted therapies].

Therapeutische Umschau. Revue therapeutique·2026

[Immune-related adverse events of immune checkpoint inhibitors].

Therapeutische Umschau. Revue therapeutique·2026

Therapeutic drug monitoring of adalimumab for dose optimization during maintenance therapy in patients with ulcerative colitis: real-world data.

Folia medica·2026

Correction: A robust and scalable immunoadsorbent platform based on the high-affinity M03-IgG antibody for targeted IL-6 Removal in cytokine storm.

Frontiers in immunology·2026

Expanded dendritic cells loaded with placental gp96 to generate antigen-specific T cells for anti-tumor immunity: an in vitro study.

Central-European journal of immunology·2026

Protein Posttranslational Modifications in Immunity: Molecular Mechanisms and Therapeutic Targets.

MedComm·2026

Related Experiment Videos

Interleukin-1 beta expression and treatment outcome in acute myelogenous leukemia

Related Concept Videos

Energy-Dependent Shifts of Medium-Scale Anisotropies in Very-High-Energy Cosmic Rays Observed by LHAASO-KM2A.

Transient Large-Scale Anisotropy in TeV Cosmic Rays due to an Interplanetary Coronal Mass Ejection.

First Detection of Ultrahigh Energy Emission from Gamma-Ray Binary LS I +61° 303.

Evidence of Cosmic-Ray Acceleration up to Sub-PeV Energies in the Supernova Remnant IC 443.

Precise Measurement of the Cosmic Ray Helium Spectrum above 0.1 PeV.

A REVIEW OF CURRENT CONCEPTS IN THE MANAGEMENT OF BONE DEFECTS IN TRAUMA AND ORTHOPAEDICS.

Vasculopathy in the Forecast: Biophysically Altered Red Cells Act as Hemodynamic Hail to Trigger Endothelial Dysfunction.

Nipocalimab for warm autoimmune hemolytic anemia: results from the phase 2/3 randomized, double-blind ENERGY study.

Inhibition of nucleoporin 214 depletes leukemia stem cells by promoting heme catabolism and lipid peroxidation.

International Consensus Criteria for the Diagnosis, Treatment Initiation, and Response Assessment for T-LGL Leukemia.

Epigenetic markers expand genetic risk estimation in acute myeloid leukemia.

Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas.

[Sarcoidosis from an immunological perspective - experience-based diagnosis and treatment with targeted therapies].

[Immune-related adverse events of immune checkpoint inhibitors].

Therapeutic drug monitoring of adalimumab for dose optimization during maintenance therapy in patients with ulcerative colitis: real-world data.

Correction: A robust and scalable immunoadsorbent platform based on the high-affinity M03-IgG antibody for targeted IL-6 Removal in cytokine storm.

Expanded dendritic cells loaded with placental gp96 to generate antigen-specific T cells for anti-tumor immunity: an in vitro study.

Protein Posttranslational Modifications in Immunity: Molecular Mechanisms and Therapeutic Targets.

Related Experiment Videos

Interleukin-1 beta expression and treatment outcome in acute myelogenous leukemia

Related Concept Videos

Related Articles